Skip to Content
KZ
EN
Products
Applications
Services
Documents
Support
Analytical Chemistry
Cell Culture & Analysis
Chemistry & Biochemicals
Clinical & Diagnostics
Filtration
Greener Alternative Products
Industrial Microbiology
Lab Automation
Labware
Materials Science
Molecular Biology & Functional Genomics
mAbs Development & Manufacturing
mRNA Development & Manufacturing
Pharma & Biopharma Manufacturing
Protein Biology
Water Purification
Analytical Chemistry
Cell Culture & Analysis
Chemistry & Synthesis
Clinical & Diagnostics
Environmental & Cannabis Testing
Food & Beverage Testing & Manufacturing
Genomics
Materials Science & Engineering
Microbiological Testing
mAbs Development & Manufacturing
mRNA Development & Manufacturing
Pharma & Biopharma Manufacturing
Protein Biology
Research & Disease Areas
Water Purification
Contract Manufacturing
Contract Testing
Custom Products
Digital Solutions for Life Science
IVD Development & Manufacturing
Product Services
Support
Safety Data Sheets (SDS)
Certificates of Analysis (COA)
Certificates of Origin (COO)
Certificates of Quality (COQ)
Customer Support
Contact Us
Get Site Smart
FAQ
Quality & Regulatory
Calculators & Apps
Webinars
Home
Search Results
Predicting pathological complete response in breast cancer early.
Predicting pathological complete response in breast cancer early.
The Lancet. Oncology (2014-12-03)
David Groheux
PMID
25456356
MATERIALS
Product Number
Brand
Product Description
F5006
Sigma-Aldrich
2-Fluoro-2-deoxy-D-glucose, glycosylation inhibitor, glucose analog
Pricing
